Correlation Between Regen BioPharma and VIRI Old
Can any of the company-specific risk be diversified away by investing in both Regen BioPharma and VIRI Old at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Regen BioPharma and VIRI Old into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Regen BioPharma and VIRI Old, you can compare the effects of market volatilities on Regen BioPharma and VIRI Old and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Regen BioPharma with a short position of VIRI Old. Check out your portfolio center. Please also check ongoing floating volatility patterns of Regen BioPharma and VIRI Old.
Diversification Opportunities for Regen BioPharma and VIRI Old
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Regen and VIRI is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Regen BioPharma and VIRI Old in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on VIRI Old and Regen BioPharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Regen BioPharma are associated (or correlated) with VIRI Old. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of VIRI Old has no effect on the direction of Regen BioPharma i.e., Regen BioPharma and VIRI Old go up and down completely randomly.
Pair Corralation between Regen BioPharma and VIRI Old
If you would invest 7.50 in Regen BioPharma on December 20, 2024 and sell it today you would lose (0.29) from holding Regen BioPharma or give up 3.87% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Flat |
Strength | Insignificant |
Accuracy | 0.0% |
Values | Daily Returns |
Regen BioPharma vs. VIRI Old
Performance |
Timeline |
Regen BioPharma |
VIRI Old |
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Regen BioPharma and VIRI Old Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Regen BioPharma and VIRI Old
The main advantage of trading using opposite Regen BioPharma and VIRI Old positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Regen BioPharma position performs unexpectedly, VIRI Old can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in VIRI Old will offset losses from the drop in VIRI Old's long position.Regen BioPharma vs. Oncology Pharma | Regen BioPharma vs. Creative Medical Technology | Regen BioPharma vs. Therasense | Regen BioPharma vs. Enzolytics |
VIRI Old vs. LMF Acquisition Opportunities | VIRI Old vs. ZyVersa Therapeutics | VIRI Old vs. Sonnet Biotherapeutics Holdings | VIRI Old vs. Revelation Biosciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stocks Directory module to find actively traded stocks across global markets.
Other Complementary Tools
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Share Portfolio Track or share privately all of your investments from the convenience of any device | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Content Syndication Quickly integrate customizable finance content to your own investment portal |